期刊文献+

盐酸缬更昔洛韦及其有关物质的合成 被引量:3

Synthesis of Valganciclovir Hydrochloride and Its Related Substances
原文传递
导出
摘要 更昔洛韦经缩合、选择性水解、氢化还原反应制得盐酸缬更昔洛韦,总收率为29.7%,终产品纯度和非对映异构体比例均符合美国药典35版要求。并合成了工艺中可能存在的3个有关物质:更昔洛韦单乙酸酯、更昔洛韦单丙酸酯和更昔洛韦双缬氨酸酯,为盐酸缬更昔洛韦的质控和纯化提供基础。 Valganciclovir hydrochloride (1) was synthesized from ganciclovir by condensation, selective hydrolysis and hydrogenation with an overall yield of 29.7%. The purity of final product and the ratio of the diastereomeric isomers were in accordance with the requirements of US pharmacopeia (USP35). Three related substances including ganciclovir monoacetate, ganciclovir monopropionate and bis-valine easter of ganciclovir were successfully synthesized, which provided the basis for the quality control and purification of 1.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第5期409-411,448,共4页 Chinese Journal of Pharmaceuticals
关键词 盐酸缬更昔洛韦 抗病毒药 有关物质 合成 valganciclovir hydrochloride antivirus agent related substance synthesis
  • 相关文献

参考文献10

  • 1Clercq ED.New inhibitors of human cytomegalovirus(HCMV) on the horizon[J].JAntimicrob Chemother,2003,51(5):1079-1083.
  • 2Cvetkovic RS,Wellington K.Valganciclovir:a review of its use in the management of CMV infection and disease in immunocompromised patients[J].Drugs,2005,65(6):859-878.
  • 3Paya C,Humar A,Dominguez E,et al.Efficacy and safety of valganciclovir vs.oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients[J].Am J Transplant,2004,4(4):611-620.
  • 4Maag H,Nestor JJ,Womble SW,et al.2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative:US,6083953[P].2000-07-04.
  • 5Dvorak CA,Wren DL,Fisher LE,et al.Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative:US,6040446[P].2000-03-21.
  • 6Arzeno HB,Beard CC,Fisher LE,et al.Process for preparing purine derivatives:WO,1997027194[P].1997-07-31.
  • 7Arzeno HB,Humphreys ER,Bruno S,et al.Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)-methoxy-1,3-propanediol derivative:US,5756736[P].1998-05-26.
  • 8Babu KS,Srinivas P,Madhavi YV,et al.A succinct synthesis of valganciclovir hydmchloride,a cytomegalovims(CMV)retinitis inhibitor[J].Arkivoc,2011,(2):199-208.
  • 9Katkam S,Sagyam RR,Ganta MR,et al.Preparation of valganciclovir and its salt:US,20110207931 A1[P].20 l 1-08-25.
  • 10李艳萍,李卓荣,山广志.抗病毒药物缬更昔洛韦的合成研究[J].中国抗生素杂志,2005,30(6):336-337. 被引量:6

二级参考文献3

  • 1Pescovitz MD. Formulary considerations for drugs used to prevent cytomegalovirus disease [J]. Am J Health Syst Pharm,2003,60(Suppl 8) :S17
  • 2Segarra-Newnham M, Salazar M I. Valganciclovir: A new oral alternative for cytomegalovirus retinitis in human immunodeficiency virus-seropositive individuals [J]. Pharmacot heropy, 2002,22 (9): 1124
  • 3John J N, Scott W W, Hans M. 2-(2-amino-1,6- dihydro-6-oxo-purin-9-yl ) methoxy-1, 3-propanediol derivative[P]. EP: 0694547,1996-01-31

共引文献5

同被引文献11

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部